Patents Assigned to Synchroneuron Inc.
  • FORMULATIONS
    Publication number: 20220184007
    Abstract: Provided herein are high-dose formulations of acamprosate in a pharmaceutically acceptable salt form, as well as methods of preparing the same, and methods of using the same.
    Type: Application
    Filed: April 2, 2020
    Publication date: June 16, 2022
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, DVM, MS, DACVP, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130310455
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 21, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130310456
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 21, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130245004
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: September 19, 2013
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130224292
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: March 29, 2013
    Publication date: August 29, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.